CD34 and acute myeloid leukemia: Although the expression levels of CD34 and CD123 tends to differ between normal stem/progenitor cells of healthy donors and AML patients (as depicted in the FACS data presented in Figure 1), CD34+CD123+ hematopoietic stem/progenitor cells can still be seen as counterparts to leukemic CD34+CD123+ cells.